3D-scanned insoles: a verification checklist and placebo-detection spreadsheet

Hook: Stop guessing — verify 3D‑scanned insoles and spot placebo effects before you trust results

Clinicians and students testing 3D‑scanned custom insoles face two recurring frustrations: time wasted cleaning up measurements and uncertainty about whether apparent clinical gains are real or driven by expectation. This documentation pack gives you a practical verification checklist, robust blinding procedures, and a ready-to-customize placebo‑detection spreadsheet designed for small‑sample insole trials in 2026.

Why this matters in 2026

By late 2025 and early 2026, consumer 3D scanning (phone photogrammetry and low‑cost structured light) is widely used to make footwear and orthotic products. Regulators and journals are increasingly demanding reproducible measurement workflows and transparent statistical verification for device claims. At the same time, placebo effects in wearable wellness tech remain strong: a visible branding, engraved logos, or perceived “customness” can drive subjective outcomes even when mechanical effects are minimal. That puts responsibility on clinicians and researchers to verify both the physical fidelity of the insole and the internal validity of their trials.

What this documentation pack delivers

• 3D scan verification checklist — stepwise QA items and thresholds for scan capture, mesh generation, and manufacturing verification.
• Blinding & trial conduct procedures — practical guidance for sham vs active control, allocation concealment, and debriefing rules appropriate to clinical settings.
• Placebo‑detection spreadsheet — sheetized design (Data, Checks, Analysis, Blinding Audit, Permutation) with formulas for paired tests, nonparametric checks, effect sizes, Bayes factors, bootstrapped CIs, and blinding indices.
• How to verify and customize calculations — explicit cell formulas, audit checks, and R/Python fallbacks for resampling tests.

Part 1 — 3D scan & manufacturing verification checklist

Before you evaluate clinical effects, confirm the product matches the scanned geometry and intended mechanical profile.

Capture & operator controls

• Document device model, firmware/app version, operator ID, and capture date/time in metadata.
• Standardize foot pose: neutral ankle, weight‑bearing defined (e.g., relaxed single‑leg vs standing), and a repeatable marker or jig for positioning.
• Record ambient lighting and background to spot photogrammetry artifacts.

Scan quality metrics

• Point density: record points/cm² or vertices/mm². Target portable scanners: >0.2 vertices/mm² for accurate surface curvature; phone photogrammetry should be tested against a reference.
• Mesh integrity: report number of holes, non‑manifold edges, and mesh watertightness. Tolerate zero holes for manufacturing CAD; set a remediation workflow for hole fills.
• Registration error: if you align multiple frames, record RMS alignment error (mm). Acceptable consumer workflow: RMS <0.8 mm for orthotic geometry; for clinical research aim for <0.5 mm.

Manufacturing & materials verification

• Document manufacturing method (CNC, milling, 3D print) and material specs (shore hardness, density).
• Dimensional verification: capture a post‑manufacture scan and compute point‑to‑surface deviation against CAD. Report mean signed deviation and RMS. Thresholds: mean <0.5 mm, RMS <1.0 mm typical; tighten for tight tolerance designs.
• Functional validation: if the claim involves arch support or pressure redistribution, report pressure map comparisons (baseline vs insole) and peak pressure reduction values with measurement device and calibration data.

Repeatability & traceability

• Scan the same foot 3 times across a week. Report inter‑session RMS deviation. Flag reproducibility concerns when RMS exceeds your tolerance.
• Keep an audit trail (scan raw files, processed meshes, manufacturing batches) and include version IDs in your dataset and the spreadsheet’s Audit sheet.

Part 2 — Blinding procedures tailored for insole trials

Design blinding to reduce expectation‑driven outcomes without violating ethical standards. The aim is effective concealment of allocation and robust assessment of blinding success.

Core blinding elements

• Use a sham insole that is visually and texturally indistinguishable from the active insole. Avoid branding, visible unique engraving, or colored edges that reveal assignment.
• Manufacture sham inserts with matched thickness and outer covering. Keep mechanical features subtle (e.g., internal stiffness differences) to avoid inadvertent unblinding.
• Double‑blind where possible: the clinician fitting the insole and the outcome assessor should be unaware of allocation. If double‑blinding is impractical, at least blind the outcome assessor and the statistician.
• Randomize allocation centrally and use sealed opaque envelopes or an electronic allocation system to prevent foreknowledge.

Expectation management and ethical consent

• Consent forms should disclose that participants will receive one of two insoles but not which; explain sham usage ethically, and describe debriefing plans.
• Measure participant expectation at baseline with a short numeric scale (e.g., “How much do you expect improvement?” 0–10). Store this as a covariate for placebo checks.

Blinding assessment

At one or more follow‑up points, ask participants and assessors to guess allocation (Active, Sham, Don’t know) and their confidence. Use quantitative indices below to summarise blinding success.

Blinding indices you can compute in the spreadsheet

• Bang’s Blinding Index (two arms): BI = 2*p - 1, where p is the proportion of correct guesses. Interpretation: 0 = perfect blinding; close to 1 indicates unblinded; negative values suggest opposite guessing.
• James’ Blinding Index: a weighted agreement measure across “active/sham/don’t know”. Use the spreadsheet’s Blinding sheet to compute both indices and confidence intervals via bootstrap.

Part 3 — The placebo‑detection spreadsheet: structure and core calculations

The spreadsheet is organized into modular sheets. Below I describe each sheet, key columns, and exact formulas you can paste into Excel or Google Sheets. The pack assumes small samples (n ≤ 30) and offers parametric and nonparametric options plus resampling methods.

Sheet: Data

Columns you should include:

1. ID — participant code
2. Arm — Active / Sham / Crossover sequence
3. Baseline — outcome at baseline (numeric)
4. Post1 — outcome after first period
5. Post2 — outcome after second period (if crossover)
6. Expectation_baseline — numeric expectancy score (0–10)
7. Guess_post — participant’s guess (Active/Sham/Don’t know)
8. Assessor_guess — assessor’s guess
9. Notes — operator, scan ID, manufacturing batch

Sheet: Checks

Automated validation rules to ensure data integrity:

• Missing values check: =COUNTBLANK(range) and conditional colouring.
• Outlier detection for each numeric column: compute median and MAD and flag values >3×MAD.
• Versioning: cell with formula ="v1.0 | " & TEXT(TODAY(),"yyyy-mm-dd") to stamp file.

Sheet: Analysis — within‑subject paired tests

Example: a parallel two‑arm pre/post design (use Type=1 paired test when appropriate). Key cells and formulas:

• Compute change scores: in Data sheet add column Delta = Post - Baseline. Example (cell G2): =E2 - C2
• Mean change (Active): =AVERAGEIF(Data!B:B,"Active",Data!G:G)
• SD of paired differences (Active): =STDEV.S(IF(Data!B:B="Active",Data!G:G)) — enter as array formula in older Excel or use FILTER in Excel 365: =STDEV.S(FILTER(Data!G:G,Data!B:B="Active"))
• Paired t‑test p‑value (Active vs Sham within subjects in crossover): =T.TEST(range_active, range_sham, 2, 1). Example: =T.TEST(FILTER(Data!G:G,Data!B:B="Active"), FILTER(Data!G:G,Data!B:B="Sham"), 2, 1)
• Cohen’s d for paired samples: d = mean_diff / sd_diff. Compute with: = (AVERAGE(diff_range)) / STDEV.S(diff_range)
• Hedges’ g small‑sample correction: = d * (1 - 3 / (4 * n - 9) )

Small‑sample & nonparametric checks

• Wilcoxon signed‑rank test (paired nonparametric): use R or Python for exact p when n < 10; in Excel use the Data Analysis add‑in or a formula extension. We include an R snippet in the Audit sheet:

  # R paired Wilcoxon exact p wilcox.test(x, y, paired=TRUE, exact=TRUE, alternative='two.sided')

• Permutation (randomization) test: for paired designs flip the sign of each participant’s difference randomly and compute mean; repeat 5,000–20,000 times and compute two‑sided p as proportion of permuted means as extreme as observed. Excel 365 can do this with RANDARRAY and LET/LAMBDA; otherwise use R (script provided in Audit sheet).
• Bootstrap CIs for mean difference and Cohen’s d: resample paired differences with replacement 5,000 times and compute percentile CIs. Use R or Python if you need exact intervals; a Google Apps Script or Excel macro can also run resamples for you.

Placebo‑detection algorithms in the Analysis sheet

These checks help distinguish a mechanical effect from expectation:

1. Expectation—Outcome correlation: compute Spearman rank correlation between baseline expectation and outcome change.
   • Spearman via ranks in Excel: =CORREL(RANK.AVG(expect_range), RANK.AVG(delta_range))
2. Within‑participant dose‑response: if you measure objective metrics (e.g., peak plantar pressure), correlate mechanical change magnitude with outcome change. A weak correlation suggests nonmechanical (placebo) drivers.
3. Blinding success vs outcome: compute difference in mean outcomes between participants who guessed correctly vs incorrectly. Use permutation to test whether guess correctness predicts outcome beyond chance.
4. Carryover & sequence checks for crossover trials: compute period by treatment interaction using a paired ANOVA or mixed model. In small samples, use nonparametric sequence checks and present individual participant trajectories graphically.

Bayesian check — Bayes factor for small samples

Bayesian t‑tests are informative in small samples. The spreadsheet includes a simplified approximation (R JZS default) via an R code snippet in Audit. If you must stay in the spreadsheet, report the effect size and bootstrap CI alongside a transparent prior assumption; when the CI excludes clinically important thresholds and the Bayes factor favors the null, suspect placebo or measurement error.

Part 4 — Example walkthrough (n = 10 crossover pilot)

Here’s a concise example you can paste into your sheet and reproduce. Assume 10 participants in a simple crossover (Active then Sham or Sham then Active). Outcome is pain score 0–100; lower is better.

Raw paired difference summary (Delta = Post − Baseline):

• Mean Delta under Active = -30
• Mean Delta under Sham = -20
• Paired difference (Active − Sham) mean = -10
• SD of paired differences = 12

Compute paired t:

t = mean_diff / (sd_diff / sqrt(n)) = -10 / (12 / sqrt(10)) = -10 / 3.795 = -2.635 → p ≈ 0.026

Interpretation: statistically significant at α=0.05, but with n=10 you must check nonparametric and placebo diagnostics:

• Compute Spearman between Expectation_baseline and (Active Delta − Sham Delta). If rho > 0.5 and p<0.05, there is a strong expectancy signal.
• Compute Bang’s index for guesses. If BI ≈ 0, blinding holds; if BI > 0.5, unblinding likely explains some effect.
• Run a 5,000‑permutation paired test; if permutation p > 0.05, treat parametric p with caution.

Part 5 — How to verify and customize the spreadsheet calculations

This section explains how to audit formulas, add new tests, and adapt to different designs.

Audit trail & reproducibility

• Keep an Audit sheet with: file author, version, date, data source, and a checksum for Data (e.g., =SUMPRODUCT(--(Data!A2:A1000<>""),ROW(Data!A2:A1000))).
• Lock key result cells and use clear named ranges (e.g., DeltaActive).

Validating critical formulas

1. Recompute the same statistic with two methods (e.g., Excel T.TEST and an R script). Compare p‑values to within acceptable rounding differences.
2. For effect sizes, compute both Cohen’s d and Hedges’ g. Implement the correction formula in the sheet: =d*(1 - 3/(4*n - 9)).
3. For nonparametric tests, cross‑validate Wilcoxon results with R’s exact test for n≤15.

Adding a permutation test inside Excel 365

Excel 365 users can implement a quick sign‑flip permutation with these steps (simplified):

1. Create a range of differences DiffRange (e.g., J2:J11).
2. Generate random signs in a matrix: =IF(RANDARRAY(5000,ROWS(DiffRange)) < 0.5, 1, -1)
3. Multiply and average across rows to get 5000 permuted means. Compute p as proportion of absolute permuted means ≥ |observed mean|.

If you don’t have Excel 365, the simplest reliable approach is to run the provided R or Python script in the Audit sheet (copy/paste). It prints permutation p and bootstrap CIs and writes a CSV you can reimport.

Part 6 — Reporting checklist & recommended pre‑specifications

Pre‑specify these items in your protocol and copy them into the spreadsheet’s Protocol cell before analysis:

• Primary outcome and timepoint
• Primary analysis method (paired t, Wilcoxon, permutation)
• Planned estimand and MCID (minimal clinically important difference)
• Handling of missing data and carryover (for crossover)
• Blinding assessment schedule and metrics

Practical takeaways

• Verify the product first — mechanical fidelity is necessary before interpreting clinical effects. Use the 3D scan checklist to quantify fidelity and tolerances.
• Design blinding carefully — sham insoles must match appearance and feel. Pretest blinding materials on volunteers to estimate the Bang index.
• Use multiple analyses — combine parametric, nonparametric, and resampling methods in the spreadsheet. For small samples, permutation and bootstrap methods are often more reliable than asymptotic p‑values.
• Test for expectation signals — correlate expectancy with outcome, and compute blinding indices. High expectancy‑outcome correlation plus failed blinding suggests placebo effects.
• Keep an auditable workflow — version your spreadsheet, stamp datasets, and include R/Python scripts for resampling tests so your results are reproducible and defensible to journal editors or regulators.

2026 trends and what to watch next

In 2026 the field is shifting toward hybrid verification: combining consumer 3D scanning with standardized mechanical benchmarks and open statistical verification. Expect journals and regulators to ask for scan RMS errors, manufacturing deviation maps, and raw de‑identified datasets along with analysis scripts. Clinicians who adopt transparent, auditable spreadsheets and pre‑specified placebo checks will be best positioned to publish and defend device claims.

Final checklist before you sign off an insole study

1. Scan QA: point density, RMS registration < your tolerance.
2. Manufacture QA: post‑scan deviation mean < 0.5 mm (adjust per device).
3. Blinding: sham indistinguishable in look/feel; Bang’s Index near 0.
4. Pre‑specification: primary outcome, MCID, statistical plan documented.
5. Analyses: paired parametric + nonparametric + permutation/bootstrapped CIs done and audited.
6. Placebo detection: expectation correlation, guess‑outcome checks, and reporting of blinding indices.

Call to action

If you’re preparing a pilot or class exercise, download the companion spreadsheet (Data, Checks, Analysis, Blinding Audit, Permutation) from our site, copy the Audit R/Python scripts into your environment, and run the verification checklist on your first five subjects before scaling up. Want custom training or a clinic‑branded version of the spreadsheet with built‑in scan QC visualisations? Contact our team for a workshop or consultancy — we’ll help you make your 3D‑scanned insole study reproducible, auditable, and meaningful.

Related Reading

• Subscription Strategies That Work: What Creators Can Learn From Goalhanger’s 250k Paying Users
• Best UK Countryside Cottages and Hotels for Dog Owners
• Social Signals for Torrent Relevance: How Features Like Live Badges and Cashtags Can Improve Ranking
• Retail Trends: How Big-Name Merchants and New MDs Shape Curtain Fabric Trends
• Limited-Edition Beauty Bags to Grab Before They Vanish (Regional Drops & Licensing Changes)